ATE403676T1 - Neue östrogenrezeptorligandenbindungsdomänen varianten und neue liganden und pharmazeutische zusammensetzungen - Google Patents

Neue östrogenrezeptorligandenbindungsdomänen varianten und neue liganden und pharmazeutische zusammensetzungen

Info

Publication number
ATE403676T1
ATE403676T1 AT02731968T AT02731968T ATE403676T1 AT E403676 T1 ATE403676 T1 AT E403676T1 AT 02731968 T AT02731968 T AT 02731968T AT 02731968 T AT02731968 T AT 02731968T AT E403676 T1 ATE403676 T1 AT E403676T1
Authority
AT
Austria
Prior art keywords
new
receptor ligand
ligand binding
pharmaceutical compositions
binding domain
Prior art date
Application number
AT02731968T
Other languages
English (en)
Inventor
Kathryn Rene Bracken
Los Angeles Joseph De
Ying Huang
Michael Kadan
Gary Ksander
Dennis Zerby
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE403676T1 publication Critical patent/ATE403676T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02731968T 2001-05-31 2002-05-31 Neue östrogenrezeptorligandenbindungsdomänen varianten und neue liganden und pharmazeutische zusammensetzungen ATE403676T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29483901P 2001-05-31 2001-05-31

Publications (1)

Publication Number Publication Date
ATE403676T1 true ATE403676T1 (de) 2008-08-15

Family

ID=23135160

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02731968T ATE403676T1 (de) 2001-05-31 2002-05-31 Neue östrogenrezeptorligandenbindungsdomänen varianten und neue liganden und pharmazeutische zusammensetzungen

Country Status (7)

Country Link
US (1) US7381813B2 (de)
EP (2) EP1397382B1 (de)
JP (1) JP2004537293A (de)
AT (1) ATE403676T1 (de)
AU (1) AU2002303903A1 (de)
DE (1) DE60228082D1 (de)
WO (1) WO2002097050A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7329728B1 (en) 1999-10-25 2008-02-12 The Scripps Research Institute Ligand activated transcriptional regulator proteins
EP2141228A1 (de) * 2001-12-18 2010-01-06 Cancer Research Technology Limited Methode zur Herstellung von proliferierenden und differenzierenden B-Zelllinien
CA2543329A1 (en) * 2003-10-24 2005-05-06 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Orthogonal gene switches
WO2007047583A2 (en) * 2005-10-18 2007-04-26 National Jewish Medical And Research Center Conditionally immortalized long-term stem cells and methods of making and using such cells
US7709253B2 (en) * 2006-08-04 2010-05-04 The Board Of Trustees Of The Leland Stanford Junior University Ligand-regulable transactivation systems, methods of use thereof, methods of detecting estrogen receptor ligands, and methods of differentiating estrogen receptor ligand agonists and antagonists
US9273115B2 (en) 2009-01-22 2016-03-01 Centre National De La Recherche Scientifique (Cnrs) Method for controlling the biological activity of a protein in a vertebrate cell
AU2017375630B2 (en) * 2016-12-12 2023-12-21 Seattle Children's Hospital (dba Seattle Children's Research Institute) Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells
KR102109820B1 (ko) * 2018-04-16 2020-05-12 한양대학교 산학협력단 비스페놀 a와의 결합력이 향상된 돌연변이 에스트로겐 수용체 단백질 및 이를 이용한 박테리아 균주
CN116323647A (zh) * 2020-05-13 2023-06-23 博纳姆治疗公司 蛋白质复合物的组合物及其使用方法
WO2022216825A1 (en) * 2021-04-06 2022-10-13 Senti Biosciences, Inc. Ert2 mutants and uses thereof
EP4320228A1 (de) * 2021-04-06 2024-02-14 Senti Biosciences, Inc. Ert2-mutanten und verwendungen davon
CN116628472B (zh) * 2023-04-28 2024-08-30 哈尔滨工程大学 一种基于特征关联的辐射源个体信号图结构映射方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2996496A (en) 1956-06-22 1961-08-15 Central Pharmacal Company Calcium substitution products of dextran
US5288641A (en) 1984-06-04 1994-02-22 Arch Development Corporation Herpes Simplex virus as a vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
JPS63502397A (ja) * 1986-02-20 1988-09-14 カロビオ　エービー ステロイドレセプタ−タンパクの真核細胞における発現
US5665577A (en) 1989-02-06 1997-09-09 Dana-Farber Cancer Institute Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof
US5436146A (en) 1989-09-07 1995-07-25 The Trustees Of Princeton University Helper-free stocks of recombinant adeno-associated virus vectors
US5672510A (en) 1990-01-19 1997-09-30 Genetic Therapy, Inc. Retroviral vectors
US5817491A (en) 1990-09-21 1998-10-06 The Regents Of The University Of California VSV G pseusdotyped retroviral vectors
WO1998018925A2 (en) 1996-10-29 1998-05-07 Valentis, Inc. Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
US5364791A (en) * 1992-05-14 1994-11-15 Elisabetta Vegeto Progesterone receptor having C. terminal hormone binding domain truncations
US6416998B1 (en) 1992-09-02 2002-07-09 Baylor College Of Medicine Plasmid encoding a modified steroid hormone
DE69334150T2 (de) 1992-05-14 2008-03-13 Baylor College Of Medicine, Houston Mutierte steroidhormonrezeptoren, methoden für ihre benutzung und molekularer schalter für gentherapie
US5534619A (en) * 1993-11-12 1996-07-09 The Board Of Regents Acting On Behalf Of University Of Michigan Peptides for heparin and low molecular weight heparin anticoagulation reversal
CA2162497A1 (en) 1993-06-10 1994-12-22 Sheila Connelly Adenoviral vectors for treatment of hemophilia
US6140466A (en) 1994-01-18 2000-10-31 The Scripps Research Institute Zinc finger protein derivatives and methods therefor
US5707865A (en) 1994-12-21 1998-01-13 Kohn; Donald B. Retroviral vectors for expression in embryonic cells
US5622856A (en) 1995-08-03 1997-04-22 Avigen High efficiency helper system for AAV vector production
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
US6140081A (en) 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
US7329728B1 (en) 1999-10-25 2008-02-12 The Scripps Research Institute Ligand activated transcriptional regulator proteins
AU2001272544B2 (en) 2000-07-18 2005-12-01 The Scripps Research Institute Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches

Also Published As

Publication number Publication date
DE60228082D1 (de) 2008-09-18
WO2002097050A3 (en) 2003-03-13
EP1397382B1 (de) 2008-08-06
EP2060582A1 (de) 2009-05-20
EP1397382A4 (de) 2005-08-24
US20030143559A1 (en) 2003-07-31
US7381813B2 (en) 2008-06-03
EP1397382A2 (de) 2004-03-17
WO2002097050A2 (en) 2002-12-05
AU2002303903A1 (en) 2002-12-09
JP2004537293A (ja) 2004-12-16

Similar Documents

Publication Publication Date Title
ATE403676T1 (de) Neue östrogenrezeptorligandenbindungsdomänen varianten und neue liganden und pharmazeutische zusammensetzungen
EP1310509A3 (de) Anti-östrogene Steroide, pharmazeutische Zusammensetzungen und Verwendungen davon
DE69930835D1 (de) Bicyclische pyridin-und pyrimidinderivate als neuropeptid y rezeptorantagonisten
ATE480252T1 (de) Peptidantagonist von zonulin und dessen verwendung
ATE365708T1 (de) Hydroxy-diaryl-carbaldehyd- oxim-verbindungen und deren verwendung als oestrogenwirksame substanzen
ATE350366T1 (de) Aryl-carbaldehyd oxime-verbindungen und deren verwendung als oestrogenwirksame substanzen
ATE360434T1 (de) April rezeptor (bcma) und verwendungen davon
BR9510486A (pt) Compostos moduladores de receptores de esteróide e métodos
DE69728392D1 (de) Indolderivate verwendbar als endothelinrezeptorantagonisten
DE69839270D1 (de) Agonistische antikörper gegen den thrombopoietinrezeptor und deren therapeutische verwendungen
DE60032249D1 (de) AMINO-SUBSTITUIERTE PYRAZOLOi1,5-Aö-1,5-PYRIMIDINE UND PYRAZOLOi1,5-Aö-1,3,5-TRIAZINE
ATE209207T1 (de) Androgen rezeptor modulator verbindungen und verfahren
ATE254920T1 (de) Neue galenische zubereitungsformen von meloxicam zur oralen applikation
NO20030443D0 (no) Fremgangsmåte for fremstilling av funksjonelle proteindomener
BR0212225A (pt) Derivados de indeno[1,2-c] isoquinolina substituìdos e processos de uso dos mesmos
NO20026168D0 (no) 3-azabicyklo(3.1.0)heksan derivater med opioid reseptor affinitet
AU7078200A (en) Polypeptides, comprising il-6 ligand-binding receptor domains and related nucleic acids, antibodies, compositions, and methods of use
DE50100358D1 (de) Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten
AU2299099A (en) Antibodies against human vegf receptor kdr
ATE220393T1 (de) Eine heteroethynylen-brücke enthaltende bi- aromatische verbindungen und diese enthaltende pharmazeutische und kosmetische zusammensetzungen
ATE321764T1 (de) Tetracyclische heteroverbindungen als modulatoren des östrogenrezeptors
ATE497947T1 (de) Neue 1,3-disubstituierte azetidinderivate zur verwendung als liganden des 5ht2a-rezeptors
DK1303539T3 (da) Hidtil ukendt medlem af EphA-receptorfamilien
DK1171470T3 (da) Antistoffer over for placentaprotein 13
FR2800758B1 (fr) Ensemble mixte pour le repandage de liant sur la chaussee pour le maintien de gravillons ou l'accrochage d'enrobe

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties